RPP News detail

Antibioresistance in France

An overview of antibioresistance in France

A therapeutic deadlock within 2050 ? How antibioresistance is becoming one of the greatest health challenges France is currently facing. Our Policy Analyst, Claire Richaud, wrote an Overview.

Read the full article on LinkedIn.